HEMEX Closes Another Successful Financing Round

HEMEX is pleased to announce the successful completion of another fundraising round. Following an oversubscribed first closing in February, our second closing of the Series C increased the round to CHF 7.1 million. · Funds will be used to make initial investments in early-stage life science startups and follow-up in subsequent rounds of its thriving portfolio companies. · Rapidly growing range of services offered to life science startups will be strengthened by hiring several new team members in clinical operations, quality assurance and regulatory affairs. · Investor Club welcomes